Nashwan-Parasound process

This novel method is the latest cure based on scientific facts. The device uses infra, audible and ultrasounds for treating patients suffering from arteriosclerosis. It stimulates the development of collateral (small-vein) circulation, resulting in the decrease or dissappearance of the complaints and symptoms.

Only 20 treatment sessions are necessary for the required effect, meaning one treatment each day. A treatment session takes 30-40 minutes. The four-week long treatment period includes from Monday to Friday treatments. The treatments are preceded by medical examination by a physician expert in the field. The aim of this examination is to survey of the patient's condition before the treatments applied (by Doppler ultrasound device). At the end of the fourth week a control examination takes place aiming at the survey of the patient's condition after the treatment applied and the discussion of the future action. The treatment is painless.

The advantages of the method:

It is painless
It can be repeated even as early as after one month
It does not have any harmful side effects
It can be performed without opening up the body
It can be performed within outpatient treatment
The everyday tasks can be performed after a treatment session

Both the scientific study performed on the device and the experience proved that significant improvement can be achieved which is manifested in the decrease of disappearance of limb numbness, cold feeling and the increase of walking distance.

The improveement achieved proved to be enduring as compared to the results of conservative therapy, however, in order to maintain the improved condition, at least one repeated cure is suggested every year. In case of the majority of the patients, some further improvments were seen due to the repeated treatment.

The Nashwan-Parasound ^Plus device is protected by Hungarian and International patent and has ORKI licence. The method is scientifically justified. The international publication of the results of the scientific study conducted on the device were published in English and German language in the German scientific journal „Perfusion”. The study justified that the treatment by the device( for Fontaine, II stage, prospectiv, double-blind, crossover study) is safe, effective, and enduring. The study was conducted by a group of scientists all are practising university vascular surgeons.